A subset of human papillomaviruses (HPVs) cause 5% of human cancers including the majority of cervical cancers. Over the current funding period, we discovered that interactions between the cervical epithelium and its stromal tumor environment are key to cervical carcinogenesis. We will test specific hypotheses for how the tumor microenvironment contributes to cervical carcinogenesis. We will also evaluate the role of mutations in cellular genes in cervical carcinogenesis based upon insights gained from The Cancer Genome Atlas initiative, and identify mutations in cancer related genes that cause cervical cancers arising in FA patients to become HPV-independent. In the second aim we will continue utilizing the recently discovered mouse papillomavirus MmuPV1 to investigate the role of high risk cutaneous HPVs in neoplastic skin disease, as seen in patients with epidermodysplasia verrucoformis, using powerful new mouse models for that disease developed in our labs. We will also study the importance of immunosuppression and epithelial progenitor cells in papillomavirus induced skin disease.

Public Health Relevance

PROJECT 1 ? NARRATIVE Papillomaviruses cause 5% of human cancers. In this project, we will investigate the interplay between viral and host factors in the development of these cancers in order to develop new approaches to prevent and treat papillomavirus-induced disease.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA022443-41
Application #
9488992
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2018-05-01
Budget End
2019-04-30
Support Year
41
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Weng, Chao; Lee, Denis; Gelbmann, Christopher B et al. (2018) Human Cytomegalovirus Productively Replicates In Vitro in Undifferentiated Oral Epithelial Cells. J Virol 92:
Bristol, Jillian A; Djavadian, Reza; Albright, Emily R et al. (2018) A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection. PLoS Pathog 14:e1007179
Romero-Masters, James C; Ohashi, Makoto; Djavadian, Reza et al. (2018) An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. PLoS Pathog 14:e1007221
UmaƱa, Angie C; Iwahori, Satoko; Kalejta, Robert F (2018) Direct Substrate Identification with an Analog Sensitive (AS) Viral Cyclin-Dependent Kinase (v-Cdk). ACS Chem Biol 13:189-199
Meyers, Jordan M; Grace, Miranda; Uberoi, Aayushi et al. (2018) Inhibition of TGF-? and NOTCH Signaling by Cutaneous Papillomaviruses. Front Microbiol 9:389
Uberoi, Aayushi; Yoshida, Satoshi; Lambert, Paul F (2018) Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1). J Virol Methods 253:11-17
Djavadian, Reza; Hayes, Mitchell; Johannsen, Eric (2018) CAGE-seq analysis of Epstein-Barr virus lytic gene transcription: 3 kinetic classes from 2 mechanisms. PLoS Pathog 14:e1007114
Chakravorty, Adityarup; Sugden, Bill (2018) Long-distance communication: Looping of human papillomavirus genomes regulates expression of viral oncogenes. PLoS Biol 16:e3000062
Chiu, Ya-Fang; Sugden, Bill (2018) Plasmid Partitioning by Human Tumor Viruses. J Virol 92:
Shin, Myeong-Kyun; Payne, Susan N; Bilger, Andrea et al. (2018) Activating Mutations in Pik3caContribute to Anal Carcinogenesis in the Presence or Absence of HPV-16 Oncogenes. Clin Cancer Res :

Showing the most recent 10 out of 434 publications